{"id":"https://openalex.org/W1998095903","doi":"https://doi.org/10.1016/j.juro.2010.02.460","title":"392 SUPPRESSION OF PROSTATE CANCER GROWTH BY A NEUTRALIZING ANTI-TRANSFORMING GROWTH FACTOR-BETA (TGF-\u03b2) ANTIBODY 1D11","display_name":"392 SUPPRESSION OF PROSTATE CANCER GROWTH BY A NEUTRALIZING ANTI-TRANSFORMING GROWTH FACTOR-BETA (TGF-\u03b2) ANTIBODY 1D11","publication_year":2010,"publication_date":"2010-03-23","ids":{"openalex":"https://openalex.org/W1998095903","doi":"https://doi.org/10.1016/j.juro.2010.02.460","mag":"1998095903"},"language":"en","primary_location":{"id":"doi:10.1016/j.juro.2010.02.460","doi":"https://doi.org/10.1016/j.juro.2010.02.460","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.juro.2010.02.460","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5115602311","display_name":"Qiang Zhang","orcid":"https://orcid.org/0000-0002-4635-3763","observed_orcids":["https://orcid.org/0000-0002-4635-3763"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qiang Zhang","raw_affiliation_strings":["Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chicago, IL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100443687","display_name":"Lin Chen","orcid":"https://orcid.org/0000-0001-7764-9412","observed_orcids":["https://orcid.org/0000-0001-7764-9412","https://orcid.org/0009-0001-3254-7700"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lin Chen","raw_affiliation_strings":["Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chicago, IL","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Brian Helfand","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian Helfand","raw_affiliation_strings":["Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chicago, IL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110476794","display_name":"Norm D. Smith","orcid":"https://orcid.org/0009-0000-7623-9200","observed_orcids":["https://orcid.org/0009-0000-7623-9200"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Norm Smith","raw_affiliation_strings":["Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chicago, IL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111571813","display_name":"Julie Xiaohong Zhu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julie Zhu","raw_affiliation_strings":["Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069845633","display_name":"Borko Javonovic","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Borko Javonovic","raw_affiliation_strings":["Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chicago, IL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100562302","display_name":"Yinglu Guo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yinglu Guo","raw_affiliation_strings":["Beijing, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beijing, People's Republic of China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030411648","display_name":"Chung Lee","orcid":"https://orcid.org/0000-0003-0855-4553","observed_orcids":["https://orcid.org/0000-0003-0855-4553"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chung Lee","raw_affiliation_strings":["Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chicago, IL","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.09244954,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"183","issue":"4S","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9340000152587891},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.9409999847412109},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.8859999775886536},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.7879999876022339},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.828000009059906},{"id":"https://openalex.org/keywords/tramp-c2-cells","display_name":"TRAMP-C2 cells","score":0.8579999804496765},{"id":"https://openalex.org/keywords/luciferase-reporter","display_name":"luciferase reporter","score":0.6430000066757202},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.6499999761581421},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.48500001430511475}],"concepts":[{"id":"https://openalex.org/C118131993","wikidata":"https://www.wikidata.org/wiki/Q423671","display_name":"Transforming growth factor","level":2,"score":0.7221530675888062},{"id":"https://openalex.org/C2778229498","wikidata":"https://www.wikidata.org/wiki/Q24785672","display_name":"Transforming growth factor beta","level":3,"score":0.623466432094574},{"id":"https://openalex.org/C111001777","wikidata":"https://www.wikidata.org/wiki/Q3562192","display_name":"TGF beta signaling pathway","level":3,"score":0.5245892405509949},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5211529731750488},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.44906654953956604},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.4291859269142151},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4146486222743988},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3140018582344055},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29389625787734985},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2766790986061096},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2154105305671692}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.juro.2010.02.460","doi":"https://doi.org/10.1016/j.juro.2010.02.460","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.juro.2010.02.460","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2008925887","https://openalex.org/W2047395753","https://openalex.org/W113256543","https://openalex.org/W1975482367","https://openalex.org/W4251188819","https://openalex.org/W7216742724","https://openalex.org/W2318800376","https://openalex.org/W2090371822","https://openalex.org/W1662874855","https://openalex.org/W1481777020"],"abstract_inverted_index":{"You":[0],"have":[1,160,345],"accessJournal":[2],"of":[3,84,122,132,146,176,213,228,232,242,257,271,304,310,313,327,332,375,402,417,427,450,467,476,483,494,592],"UrologyProstate":[4],"Cancer:":[5],"Basic":[6],"Research":[7],"III1":[8],"Apr":[9],"2010392":[10],"SUPPRESSION":[11],"OF":[12],"PROSTATE":[13],"CANCER":[14],"GROWTH":[15,20],"BY":[16],"A":[17],"NEUTRALIZING":[18],"ANTI-TRANSFORMING":[19],"FACTOR-BETA":[21],"(TGF-\u03b2)":[22],"ANTIBODY":[23],"1D11":[24,262,325,359,454],"Qiang":[25,42,533],"Zhang,":[26],"Lin":[27,48,542],"Chen,":[28],"Brian":[29,54,551],"Helfand,":[30],"Norm":[31,60,560],"Smith,":[32],"Julie":[33,66,569],"Zhu,":[34],"Borko":[35,72,578],"Javonovic,":[36],"Yinglu":[37,78,587],"Guo,":[38],"and":[39,87,136,210,289,308,315,334,342,351,363,382,385,390,404,440,510,528],"Chung":[40,88,599],"Lee":[41,90,600],"ZhangQiang":[43],"Zhang":[44,534],"Chicago,":[45,51,57,63,75,91,535,544,553,562,580,601],"IL":[46,52,58,64,76,92,536,545,554,563,581,602],",":[47,53,59,65,71,77,86],"ChenLin":[49],"Chen":[50,543],"HelfandBrian":[55],"Helfand":[56,552],"SmithNorm":[61],"Smith":[62,561],"ZhuJulie":[67],"Zhu":[68,570],"Boston,":[69,571],"MA":[70,572],"JavonovicBorko":[73],"Javonovic":[74,579],"GuoYinglu":[79],"Guo":[80,588],"Beijing,":[81,589],"People's":[82,590],"Republic":[83,591],"China":[85,593],"LeeChung":[89],"View":[93],"All":[94,295,609],"Author":[95,531],"Informationhttps://doi.org/10.1016/j.juro.2010.02.460AboutPDF":[96],"ToolsAdd":[97],"to":[98,203,250,434,491],"favoritesDownload":[99],"CitationsTrack":[100],"CitationsPermissionsReprints":[101],"ShareFacebookTwitterLinked":[102],"InEmail":[103],"INTRODUCTION":[104],"AND":[105],"OBJECTIVES":[106],"Transforming":[107],"growth":[108],"factor-\u03b2":[109],"(TGF-\u03b2)is":[110],"a":[111,152,166,216,258],"potent":[112],"immunosuppressant":[113],"molecule.":[114],"In":[115,139,320],"previous":[116],"studies,":[117],"we":[118,142],"showed":[119],"that":[120,374,448],"over-production":[121],"TGF-\u03b2":[123,477],"by":[124,151,414,473,505,523,539,548,557,566,575,584,596,605],"prostate":[125,149,184,314,403,484],"cancer":[126,150,185,485],"derived":[127],"cells":[128,187,234],"results":[129,479],"in":[130,207,338,353,358,377,480,499],"evasion":[131],"host":[133,458,468],"immune":[134,459,470],"surveillance":[135],"tumor":[137,205,272,349,451],"progression.":[138],"this":[140,191,540,549,558,567,576,585,597,606],"study,":[141],"explored":[143],"the":[144,177,211,226,238,269,296,321,336,354,400,412,415,425,457,481,492,500],"potential":[145],"immunotherapy":[147],"for":[148,465],"specific":[153,259],"neutralizing":[154,260],"anit-TGF-\u03b2":[155],"antibody":[156,265],"1D11.":[157],"METHODS":[158],"We":[159],"obtained":[161],"an":[162],"expression":[163],"vector":[164],"with":[165,190,254,324,423],"triple":[167],"fusion":[168],"protein,":[169],"containing":[170],"HSV1-tk-GFP-luciferase":[171],"(SFG-nTGL)":[172],"from":[173],"Dr.Vladimir":[174],"Ponomarev":[175],"Memorial":[178],"Sloan":[179],"Kettering":[180],"Cancer":[181],"Center.":[182],"Mouse":[183],"TRAMP-C2":[186],"are":[188,247],"transfected":[189],"reporter":[192],"gene,":[193],"designated":[194],"as":[195],"TRAMP-luciferase.":[196],"This":[197,487],"new":[198],"approach":[199,227],"will":[200],"allow":[201],"us":[202],"monitor":[204,416],"load":[206],"intact":[208],"animals":[209,376],"effects":[212],"therapy":[214],"through":[215],"noninvasive":[217],"bioluminescence":[218,418],"imaging":[219],"technology.":[220],"The":[221,306,347,445],"study":[222,488],"was":[223,361],"initiated":[224],"using":[225],"subcutaneous":[229],"(sc)":[230],"injection":[231,256,303],"TRAMP-luciferase":[233],"(5x106":[235],"cells)":[236],"into":[237],"right":[239],"flank":[240],"region":[241],"30":[243],"C57BL/6":[244],"mice.":[245],"Animals":[246],"randomly":[248],"assigned":[249],"three":[251],"groups":[252,413,437],"following":[253],"intraperitoneal":[255],"anti-TGF-?antibody":[261],"or":[263],"control":[264,343],"13C4":[266,339,378],"respectively":[267,366],"at":[268],"time":[270,302],"cell":[273],"injection.":[274],"Group":[275,282,290],"1:1D11":[276],"(50":[277,284],"mg/kg":[278,285],"every":[279,286],"3":[280,287],"days);":[281],"2:13C4":[283],"days),":[288],"3:":[291],"no":[292,386,396,407],"treatment":[293,340,379,387,422],"control.":[294],"mice":[297,329,337,357],"were":[298,317,330],"killed":[299],"after":[300],"15":[301],"antibodies.":[305],"size":[307],"weight":[309,312,350,401,426],"tumor,":[311,333],"spleen":[316,428],"measured.":[318],"RESULTS":[319],"group":[322,341,344,360,380,388],"treated":[323],"1":[326],"10":[328],"free":[331],"all":[335,411],"tumors.":[346],"average":[348],"volume":[352],"remaining":[355],"9":[356],"5.3g":[362],"6.85":[364],"cm2":[365],"which":[367,461],"is":[368,395,406],"almost":[369],"2-5":[370],"folds":[371],"less":[372],"than":[373],"(15.8mg":[381],"12.85":[383],"mm2)":[384,392],"(31.4mg":[389],"23.39":[391],"(P<0.01).":[393],"There":[394],"significant":[397,408],"difference":[398],"on":[399,410],"there":[405],"metastasis":[409],"imaging.":[419],"Interestingly,":[420],"upon":[421],"1D11,":[424],"(101":[429],"mg)":[430],"increased":[431],"when":[432],"compared":[433],"another":[435],"two":[436],"76.4":[438],"mg":[439,442],"80.4":[441],"respectively.":[443],"CONCLUSIONS":[444],"data":[446],"indicated":[447],"neutralization":[449],"secreted":[452],"TGF-?by":[453],"may":[455,489],"induce":[456],"response":[460,471],"could":[462],"be":[463],"helpful":[464],"recovery":[466],"anti-tumor":[469],"inhibited":[472],"TGF-\u03b2.The":[474],"inhibition":[475],"then":[478],"suppression":[482],"growth.":[486],"lead":[490],"development":[493],"effective":[495],"antitumor":[496],"therapeutic":[497],"strategies":[498],"near":[501],"future.":[502],"\u00a9":[503],"2010":[504,522],"American":[506,524],"Urological":[507,525],"Association":[508,526],"Education":[509,527],"Research,":[511,529],"Inc.FiguresReferencesRelatedDetails":[512],"Volume":[513],"183Issue":[514],"4SApril":[515],"2010Page:":[516],"e155":[517],"Advertisement":[518,610,611],"Copyright":[519],"&":[520],"Permissions\u00a9":[521],"Inc.Metrics":[530],"Information":[532],"More":[537,546,555,564,573,582,594,603],"articles":[538,547,556,565,574,583,595,604],"author":[541,550,559,568,577,586,598,607],"Expand":[608],"PDF":[612],"downloadLoading":[613],"...":[614]},"counts_by_year":[],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2016-06-24T00:00:00"}